IG 276
Pill imprint IG 276 has been identified as Hydroxyzine 25 mg.
Hydroxyzine is used in the treatment of pain; anxiety; nausea/vomiting; sedation; allergies (and more), and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy.
Hydroxyzine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydroxyzine Images
- Imprint:
-
IG
276 - Strength:
- 25 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
calcium phosphate dibasic anhydrous
lactose monohydrate
magnesium stearate
microcrystalline cellulose
titanium dioxide
hypromellose
polyethylene glycol 400
polysorbate 80
- Drug Class:
- Antihistamines
Miscellaneous anxiolytics, sedatives and hypnotics - Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0361
More Hydroxyzine resources
- Hydroxyzine
- Hydroxyzine (Wolters Kluwer)
- Hydroxyzine Capsules (Wolters Kluwer)
- Hydroxyzine Suspension (Wolters Kluwer)
- Hydroxyzine Syrup (Wolters Kluwer)
- Rezine (Cerner Multum)
- hydroxyzine (Cerner Multum)
- Hydroxyzine Hydrochloride (AHFS DI)
- Hydroxyzine Pamoate (AHFS DI)
- Hydroxyzine (FDA)
- Hydroxyzine Capsules (FDA)
- Hydroxyzine Injection (FDA)
- Hydroxyzine Oral Solution (FDA)
- Hydroxyzine Pamoate (FDA)
- Hydroxyzine Syrup (FDA)
- Hydroxyzine Tablets (FDA)
- Hydroxyzine (Wolters Kluwer)


